Secukinumab

Uses of Secukinumab

Treatment of moderate to severe plaque psoriasis
Management of psoriatic arthritis
Treatment of ankylosing spondylitis

How Secukinumab Works

Secukinumab binds to and inhibits interleukin-17A (IL-17A), a cytokine that plays a key role in causing inflammation, thus reducing symptoms and disease progression.

Benefits of Secukinumab

Effectively reduces skin lesions and joint inflammation
Improves quality of life in autoimmune disease patients
Targets specific immune pathways for precise treatment

How to Take Secukinumab

Secukinumab is administered by subcutaneous injection, typically once a week for the first month, then monthly thereafter. Follow your healthcare provider`s instructions carefully.

Type of Dosage Available

Pre-filled syringe for subcutaneous injection

Side Effects of Secukinumab

Upper respiratory infections
Headache
Fatigue
Injection site reactions
Possible increased risk of infections

Safety Advice

Inform your doctor if you have infections or immune system problems
Avoid live vaccines during treatment
Report any signs of infection immediately
Do not stop treatment without consulting your doctor

Frequently Asked Questions (FAQs)

Q. What conditions does Secukinumab treat?
A. It is used for plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis.

Q. How is Secukinumab administered?
A. By subcutaneous injection, following the prescribed schedule.

Q. Can Secukinumab increase infection risk?
A. Yes, it may increase the risk of infections, so report symptoms early.

Q. Are there side effects at the injection site?
A. Yes, mild reactions like redness or pain may occur.

Q. Should I avoid vaccines during treatment?
A. Avoid live vaccines while on Secukinumab.

Medicine Not Available for Secukinumab